Cambridge University Hospitals, as part of the Cancer Research UK Cambridge Centre, has achieved re-accreditation by the Organisation of European Cancer Institutes (OECI) as a Comprehensive Cancer Centre for a further five years.
This is a prestigious designation which is only given to the top 20 cancer centres in Europe, including NKI in Amsterdam, L'Institut Curie and Gustave Roussy in Paris, and the Christie in Manchester.
The accreditation covers both the quality of the clinical cancer services in CUH and our neighbours at Royal Papworth, and all the research activities of the Cancer Centre, from basic to clinical research.
For more information visit: CUH News
Published March 26, 2020
A clinical trial at Addenbrooke's Hospital, Cambridge is the first to explore using precision immunotherapies to treat pancreatic cancer, one of the hardest…
Researchers at NIHR Cambridge Biomedical Research Centre have shown that a new treatment approach significantly improves survival rates for patients with…
A pioneering trial, led from Cambridge Biomedical Research Centre, has shown that…